Exploring Nanotechnology for Myofibroblast-Specific Inhibition of Rho Kinase-MRTF-SRF Pathway

Time: 9:30 am
day: Day Two


• Exploring the role Rho Kinase-MRTF-SRF pathway in myofibroblast activity and fibrotic lung diseases

• Defining nanotechnology-based myofibroblast inhibition as a novel and promising approach

• Exploring the new possibilities of nanotechnology and the promise it holds for targeted drug delivery in the lungs